Spironolactone Tablets
Spironolactone is commonly supplied as an oral tablet. Check the labeled amount per tablet and total package quantity on each individual product listing.
Aldosterone Antagonist & Potassium-Sparing Diuretic
Browse Spironolactone products and compare labeled tablet strengths, package quantities, manufacturers, published lab reports and current USA Domestic or International Warehouse availability.
Aldosterone Antagonist & Potassium-Sparing Diuretic
The Spironolactone category brings together available products containing this mineralocorticoid receptor antagonist and potassium-sparing diuretic. Spironolactone has established medical applications involving fluid balance, blood pressure and aldosterone-related conditions, while also possessing antiandrogenic properties. Browse available products and compare labeled tablet strengths, package quantities, manufacturers, published laboratory testing, pricing and USA Domestic or International warehouse availability.
Spironolactone is commonly supplied as an oral tablet. Check the labeled amount per tablet and total package quantity on each individual product listing.
Products can differ in labeled tablet strength, package quantity and manufacturer even when they contain the same active pharmaceutical ingredient.
Where laboratory reports are available, individual product pages provide access to measured results, testing dates and reported batch information.
Spironolactone products may be stocked in the USA Domestic Warehouse, International Warehouse or both depending on current inventory.
Spironolactone is a prescription medicine classified primarily as a mineralocorticoid receptor antagonist and potassium-sparing diuretic. It interferes with the effects of aldosterone, a hormone involved in regulating sodium, potassium and fluid balance.
Unlike many conventional diuretics, Spironolactone reduces sodium and water retention while limiting potassium loss. This potassium-sparing characteristic is an important part of both its therapeutic use and its safety profile.
Spironolactone identifies the active pharmaceutical ingredient. Aldactone is a well-known brand name associated with Spironolactone, while generic and manufacturer-specific products can use other branding and packaging.
When comparing products, check the active substance, labeled tablet strength, package quantity and manufacturer rather than relying solely on a familiar brand name.
Spironolactone primarily works by antagonizing mineralocorticoid receptors, reducing the physiological effects of aldosterone.
Aldosterone normally promotes sodium retention and potassium excretion in the kidneys. By reducing this signaling, Spironolactone can increase sodium and water excretion while decreasing the amount of potassium lost.
This mechanism distinguishes Spironolactone from substances that influence body weight through thyroid hormones, adrenergic stimulation or reduced dietary-fat absorption.
A diuretic increases the excretion of water and electrolytes through the kidneys. Different classes of diuretics affect electrolyte balance in different ways.
Spironolactone is described as potassium-sparing because it can reduce potassium excretion. This differs from diuretics that can substantially increase potassium loss.
Potassium-sparing does not mean electrolyte monitoring is unnecessary. In fact, excessive potassium accumulation is one of the important risks associated with Spironolactone.
Spironolactone has several established medical applications. These include selected cases involving heart failure, hypertension, edema and excessive aldosterone activity.
The appropriate use depends on the underlying condition, kidney function, electrolyte status, other medicines and individual cardiovascular considerations.
Its clinical role as an aldosterone antagonist should be distinguished from non-medical interest in temporary changes in body water or appearance.
In addition to its effects on aldosterone, Spironolactone has antiandrogenic properties. It can interfere with androgen signaling through mechanisms that differ from its primary diuretic activity.
These properties explain why Spironolactone is also encountered in medical discussions involving certain androgen-related conditions, including acne and unwanted hair growth in appropriate patients.
The antiandrogenic effects are pharmacologically distinct from the mechanism of anabolic-androgenic steroids and should not be interpreted simply as an opposite version of an anabolic drug.
Spironolactone and Finasteride can both appear in discussions involving androgen-related conditions, but their mechanisms are substantially different.
Finasteride inhibits 5-alpha-reductase, reducing conversion of testosterone into dihydrotestosterone (DHT). Spironolactone has broader antiandrogenic properties while primarily functioning clinically as a mineralocorticoid receptor antagonist.
The two medicines should therefore not be considered interchangeable simply because both can influence androgen-related physiology.
Dutasteride is another 5-alpha-reductase inhibitor and reduces formation of DHT by inhibiting the enzymes involved in testosterone-to-DHT conversion.
Spironolactone does not primarily work by blocking that conversion. Its antiandrogenic activity involves different mechanisms, while its principal pharmacological classification remains an aldosterone antagonist and potassium-sparing diuretic.
Understanding this distinction is useful when comparing products associated with androgen signaling, hair loss, acne or other hormone-related contexts.
When browsing Spironolactone products, useful comparison points include the labeled amount per tablet, total tablet count, manufacturer, current price, warehouse location and published laboratory testing where available.
Products containing the same active pharmaceutical ingredient can differ in strength, package quantity and manufacturer-specific presentation. Review the complete product specification rather than comparing products by packaging or price alone.
The labeled mg-per-tablet strength identifies the amount of Spironolactone stated for each tablet. Package quantity separately identifies the total number of tablets supplied.
Two Spironolactone products can therefore contain the same active substance while differing in tablet strength or package quantity. Check both specifications when comparing available products.
Selected Spironolactone products may have published laboratory reports that provide an additional reference point when comparing the labeled specification with the measured result reported for a submitted sample.
Where testing is available, review the identified active substance, measured result, testing date and reported batch number. If multiple reports have been published, results from different batches or testing dates can be reviewed individually.
Each laboratory report applies to the submitted sample identified in that analysis. A result from one sample does not independently verify every tablet, package or future production batch.
Because Spironolactone is a diuretic, changes in fluid balance can produce changes in scale weight and visible water retention. These changes should not be confused with loss of body fat.
A reduction in body water can cause body weight to decrease without representing a comparable reduction in adipose tissue. Likewise, changes in visible definition resulting from altered fluid balance do not indicate that the medicine has directly increased fat oxidation.
This distinction is particularly important when diuretics appear within physique-oriented product catalogs.
Diuretics can appear in bodybuilding discussions because manipulating body water may temporarily change scale weight and physical appearance. Spironolactone's potassium-sparing properties sometimes lead to additional interest in this context.
However, altering fluid and electrolyte balance can carry significant medical risks. "Potassium-sparing" should not be interpreted as meaning that Spironolactone is a safer or self-regulating method of reducing body water.
Spironolactone also has antiandrogenic effects that can be particularly relevant in an anabolic-steroid context rather than desirable for every individual.
This category therefore explains why Spironolactone may appear in physique-related catalogs without providing dehydration strategies, competition-preparation protocols or diuretic dosing schedules.
One of the most important considerations with Spironolactone is its ability to increase blood potassium. Excessively high potassium is known as hyperkalemia.
Risk can be greater in people with impaired kidney function or when Spironolactone is combined with other medicines or supplements that increase potassium.
Significant hyperkalemia can affect normal cardiac electrical activity. Electrolyte and kidney-function monitoring can therefore be important during medically supervised treatment.
The kidneys play a central role in maintaining fluid and electrolyte balance, making renal function particularly relevant to Spironolactone treatment.
Reduced kidney function can increase the risk of potassium accumulation and other complications. Concurrent medicines affecting kidney function, blood pressure or the renin-angiotensin-aldosterone system can also change the risk profile.
This is why Spironolactone cannot be evaluated solely by its visible effect on water retention or scale weight.
Spironolactone can interact with medicines and supplements that influence potassium, kidney function or blood pressure.
Potassium supplements and potassium-containing salt substitutes are particularly relevant because Spironolactone already reduces potassium excretion. Other prescription medicines can also increase the likelihood of hyperkalemia or excessive changes in blood pressure.
A complete medication and supplement list is therefore important when Spironolactone is being considered or monitored medically.
Spironolactone is a pharmacologically active prescription medicine. Important risks include hyperkalemia, changes in blood pressure, dehydration and alterations in kidney function.
Its endocrine effects can also produce adverse reactions related to altered androgen and sex-hormone signaling. The specific effects and their relevance vary according to the individual and clinical context.
Kidney function, electrolyte status, other medications and underlying cardiovascular conditions can materially affect the safety of treatment.
A published laboratory report can provide information about an analyzed product sample but does not establish that taking Spironolactone is medically appropriate or safe for an individual. This category is intended for product identification and comparison and does not provide individualized diuretic, bodybuilding or hormone-management guidance.
No. Spironolactone is not a fat burner. It is primarily an aldosterone antagonist and potassium-sparing diuretic.
A decrease in body weight caused by increased water excretion represents a change in fluid balance rather than direct loss of stored body fat.
This distinguishes Spironolactone from other products that may appear in a broader weight-management or physique catalog because of completely different pharmacological mechanisms.
Spironolactone products may be available from the USA Domestic Warehouse, the International Warehouse, or both. Available manufacturers, tablet strengths and stock levels can differ between warehouse locations.
For delivery within the United States, USA Domestic shipments typically take 4–5 business days after dispatch, while International Warehouse shipments typically take 15–20 business days after dispatch.
Delivery estimates begin after dispatch and do not include order processing time. Additional delivery, tracking and reship information is available on the Shipping Information page.
Bitcoin and other supported cryptocurrencies are available at checkout. When comparing Spironolactone products, review the manufacturer, labeled tablet strength, package quantity, current price, available laboratory reports and warehouse location.
Payment options and warehouse availability do not determine whether Spironolactone is medically appropriate for an individual. Where the store's separate crypto discount applies, eligibility depends on the current pricing status of the product.